← Back to headlines
MiMedx Stock Rises Following Analyst Upgrade on Sanara Deal
Shares of tissue-regeneration company MiMedx climbed after Craig-Hallum raised its price target, citing positive developments surrounding the company's acquisition of Sanara MedTech.
27 Aug, 16:22 — 27 Aug, 16:22
Sources
Showing 1 of 1 sources
